These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24595408)

  • 21. Clinical effectiveness and safety of OROS® hydromorphone in break-through cancer pain treatment: a multicenter, prospective, open-label study in Korean patients.
    Lee KH; Kim MK; Hyun MS; Kim JY; Park KU; Song HS; Lee SA; Lee WS; Bae SH; Ryoo HM; Cho YY
    J Opioid Manag; 2012; 8(4):243-52. PubMed ID: 22941852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
    Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ
    Clin Drug Investig; 2015 Dec; 35(12):815-22. PubMed ID: 26507617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients.
    Valeberg BT; Rustøen T; Bjordal K; Hanestad BR; Paul S; Miaskowski C
    Eur J Pain; 2008 Jul; 12(5):582-90. PubMed ID: 18023377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
    Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
    Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study.
    Rodríguez MJ; de la Torre R; Ortega JL; Trinidad JM; Benítez D; Jiménez AJ; Sanz-Yagüe A; Soler B; Torres LM
    Curr Med Res Opin; 2018 Apr; 34(4):701-709. PubMed ID: 28914555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breakthrough cancer pain: an observational study of 1000 European oncology patients.
    Davies A; Buchanan A; Zeppetella G; Porta-Sales J; Likar R; Weismayr W; Slama O; Korhonen T; Filbet M; Poulain P; Mystakidou K; Ardavanis A; O'Brien T; Wilkinson P; Caraceni A; Zucco F; Zuurmond W; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M
    J Pain Symptom Manage; 2013 Nov; 46(5):619-28. PubMed ID: 23523361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study.
    Gatti A; Gentili M; Baciarello M; Lazzari M; Marzi R; Palombo E; Sabato AF; Fanelli G
    Pain Res Manag; 2014; 19(6):e168-71. PubMed ID: 24945289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
    Brogan SE; Winter NB; Okifuji A
    Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demographic, clinical, and pain characteristics are associated with average pain severity groups in a sample of oncology outpatients.
    Valeberg BT; Miaskowski C; Hanestad BR; Bjordal K; Paul S; Rustøen T
    J Pain; 2008 Oct; 9(10):873-82. PubMed ID: 18571988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the traditional definition of breakthrough pain: an observational study.
    Gatti A; Gentili M; Iorno V; Mammucari M; Tufaro G; Lazzari M; Sabato AF
    Adv Ther; 2013 Mar; 30(3):298-305. PubMed ID: 23444055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pain and its interference with daily activities in medical oncology outpatients.
    Te Boveldt N; Vernooij-Dassen M; Burger N; Ijsseldijk M; Vissers K; Engels Y
    Pain Physician; 2013; 16(4):379-89. PubMed ID: 23877454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.
    Hernanz de Lucas R; Nuñez Fernández M; Gómez-Caamaño A; Morera López R; Fortes de la Torre I; de la Torre Tomás A; Muñoz-Garzón V; López Bermudo C; Mañas Rueda A
    Future Oncol; 2021 Mar; 17(8):943-954. PubMed ID: 33289432
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
    Kurita GP; Sjøgren P; Ekholm O; Kaasa S; Loge JH; Poviloniene I; Klepstad P
    J Clin Oncol; 2011 Apr; 29(10):1297-303. PubMed ID: 21357785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications.
    Valeberg BT; Miaskowski C; Hanestad BR; Bjordal K; Moum T; Rustøen T
    Clin J Pain; 2008 Sep; 24(7):627-36. PubMed ID: 18716502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.
    Mercadante S; Vellucci R; Cuomo A; Adile C; Cortegiani A; Valle A; Villari P; Casuccio A
    Support Care Cancer; 2015 May; 23(5):1349-54. PubMed ID: 25351457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature.
    Deandrea S; Corli O; Consonni D; Villani W; Greco MT; Apolone G
    J Pain Symptom Manage; 2014 Jan; 47(1):57-76. PubMed ID: 23796584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inadequate pain management in cancer patients attending an outpatient palliative radiotherapy clinic.
    Vuong S; Pulenzas N; DeAngelis C; Torabi S; Ahrari S; Tsao M; Danjoux C; Barnes T; Chow E
    Support Care Cancer; 2016 Feb; 24(2):887-892. PubMed ID: 26209950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patients.
    Twomey F; O'Brien T; O'Reilly M; Bogan C; Fleming J
    Ir Med J; 2015 Jun; 108(6):174-6. PubMed ID: 26182800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
    Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
    Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.